Velocity’s research site in Banning was founded in 2016 as part of Advanced Clinical Research’s strategic expansion efforts. Acquired by Velocity in 2019, Advanced Clinical Research was founded in 1984 as the first community-based clinical research center in Idaho and Utah.
Located approximately 30 miles east of Palm Springs, CA, the site is situated just north of I-10, adjacent to a local hospital and an Urgent Care Center. Parking for study participants and sponsors is on site. Velocity Banning provides multi-therapeutic expertise in a number of internal medicine indications with a focus on Family Medicine. In addition, this site has experience in conducting vaccine trials. Banning has access to diverse patient demographics, including a large Latinx population, as well as a local Pacific Islander community. All trials conducted at the site are performed in accordance with ICH and FDA guidelines, and in compliance with GCP. The Banning team is committed to being a resource for study participants, to providing the highest quality of patient care with compassion and kindness, and to advancing medicine through research.